ATE430575T1 - Laspartomycin-derivate, sowie ihre herstellung und verwendung - Google Patents
Laspartomycin-derivate, sowie ihre herstellung und verwendungInfo
- Publication number
- ATE430575T1 ATE430575T1 AT01953501T AT01953501T ATE430575T1 AT E430575 T1 ATE430575 T1 AT E430575T1 AT 01953501 T AT01953501 T AT 01953501T AT 01953501 T AT01953501 T AT 01953501T AT E430575 T1 ATE430575 T1 AT E430575T1
- Authority
- AT
- Austria
- Prior art keywords
- laspartomycin
- methods
- derivatives
- antimicrobial
- making
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 230000000845 anti-microbial effect Effects 0.000 abstract 3
- 230000000813 microbial effect Effects 0.000 abstract 2
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/10—Materials in mouldable or extrudable form for sealing or packing joints or covers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/04—Homopolymers or copolymers of ethene
- C08L23/08—Copolymers of ethene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L51/00—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L51/06—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to homopolymers or copolymers of aliphatic hydrocarbons containing only one carbon-to-carbon double bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/14—Applications used for foams
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/04—Homopolymers or copolymers of ethene
- C08L23/08—Copolymers of ethene
- C08L23/0846—Copolymers of ethene with unsaturated hydrocarbons containing other atoms than carbon or hydrogen atoms
- C08L23/0869—Acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/10—Materials in mouldable or extrudable form for sealing or packing joints or covers
- C09K2003/1034—Materials or components characterised by specific properties
- C09K2003/1037—Intumescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2200/00—Chemical nature of materials in mouldable or extrudable form for sealing or packing joints or covers
- C09K2200/06—Macromolecular organic compounds, e.g. prepolymers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2200/00—Chemical nature of materials in mouldable or extrudable form for sealing or packing joints or covers
- C09K2200/06—Macromolecular organic compounds, e.g. prepolymers
- C09K2200/0615—Macromolecular organic compounds, e.g. prepolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C09K2200/0617—Polyalkenes
- C09K2200/062—Polyethylene
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2200/00—Chemical nature of materials in mouldable or extrudable form for sealing or packing joints or covers
- C09K2200/06—Macromolecular organic compounds, e.g. prepolymers
- C09K2200/0615—Macromolecular organic compounds, e.g. prepolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C09K2200/0622—Polyvinylalcohols, polyvinylacetates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21905900P | 2000-07-17 | 2000-07-17 | |
US22095000P | 2000-07-26 | 2000-07-26 | |
US09/760,328 US6511962B1 (en) | 2000-07-17 | 2001-01-12 | Derivatives of laspartomycin and preparation and use thereof |
PCT/US2001/022353 WO2002005838A1 (en) | 2000-07-17 | 2001-07-17 | Derivatives of laspartomycin and preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE430575T1 true ATE430575T1 (de) | 2009-05-15 |
Family
ID=27396619
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01957162T ATE376557T1 (de) | 2000-07-17 | 2001-07-17 | Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika |
AT01953501T ATE430575T1 (de) | 2000-07-17 | 2001-07-17 | Laspartomycin-derivate, sowie ihre herstellung und verwendung |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01957162T ATE376557T1 (de) | 2000-07-17 | 2001-07-17 | Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika |
Country Status (10)
Country | Link |
---|---|
US (1) | US6511962B1 (de) |
EP (2) | EP1311281B1 (de) |
JP (2) | JP2004528268A (de) |
AT (2) | ATE376557T1 (de) |
AU (2) | AU2001275943B2 (de) |
CA (2) | CA2450747A1 (de) |
DE (2) | DE60138629D1 (de) |
DK (1) | DK1309336T3 (de) |
HK (1) | HK1053613A1 (de) |
WO (1) | WO2002005838A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6790829B1 (en) | 1997-07-25 | 2004-09-14 | Seatek Marine Biotechnology, Inc. | Cyclic decapeptide antibiotics |
US6716962B2 (en) * | 2000-07-17 | 2004-04-06 | Micrologix Biotech Inc. | Extractive purification of lipopeptide antibiotics |
US6737403B2 (en) * | 2000-07-17 | 2004-05-18 | Micrologix Biotech Inc. | Derivatives of laspartomycin and preparation and use thereof |
US6750199B2 (en) * | 2000-07-17 | 2004-06-15 | Micrologix Biotech Inc. | Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
AU2003240545A1 (en) | 2002-06-06 | 2003-12-22 | Therapeutics Corporation Genome | Use of ramoplanin to treat diseases associated with the use of antibiotics |
US7018996B2 (en) | 2002-07-11 | 2006-03-28 | Wyeth Holdings Corporation | Antibiotics AW998A, AW998B, AW998C and AW998D |
US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
DE102004060750A1 (de) * | 2004-12-15 | 2006-07-13 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Deacylierung von Lipopeptiden |
NZ593892A (en) | 2008-12-23 | 2013-11-29 | Biosource Pharm Inc | Antibiotic compositions for the treatment of gram negative infections |
AU2011254206B2 (en) | 2010-05-20 | 2015-06-25 | Ecolab Usa Inc. | Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof |
US8415307B1 (en) | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
KR101522625B1 (ko) * | 2013-03-15 | 2015-05-22 | 서울대학교산학협력단 | 신규한 사이클릭 펩티드 화합물, 이의 용도, 및 이의 생산 방법 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB897581A (en) * | 1958-11-14 | 1962-05-30 | American Cyanamid Co | Preparation of a new antibiotic aspartocin |
US3639582A (en) * | 1967-04-14 | 1972-02-01 | Zaidan Hojin Biseibutsu | Antibiotic laspartomycin |
FR2124060B1 (de) | 1971-02-02 | 1974-04-12 | Rhone Poulenc Sa | |
US4331594A (en) | 1978-10-16 | 1982-05-25 | Eli Lilly And Company | A-21978 Antibiotics and process for their production |
JPS5795992A (en) | 1980-12-04 | 1982-06-15 | Nippon Kayaku Co Ltd | Novel derivative of cephamycin c and its preparation |
US4524135A (en) | 1982-05-21 | 1985-06-18 | Eli Lilly And Company | A-21978C cyclic peptides |
US4800157A (en) | 1985-09-09 | 1989-01-24 | Eli Lilly And Company | Process for producing the A-21978C antibiotics |
CA1315229C (en) | 1987-06-10 | 1993-03-30 | Patrick J. Baker | Chromatographic purification process |
US5039789A (en) | 1988-04-11 | 1991-08-13 | Eli Lilly And Company | A54145 cyclic peptides |
US5028590A (en) | 1988-04-11 | 1991-07-02 | Eli Lilly And Company | Derivatives of A54145 cyclic peptides |
US4977083A (en) | 1988-04-11 | 1990-12-11 | Eli Lilly And Company | Processes for preparing A54145 compounds |
US4994270A (en) | 1988-04-11 | 1991-02-19 | Eli Lilly And Company | A54145 antibiotics and process for their production |
TW455591B (en) | 1993-06-08 | 2001-09-21 | Hoechst Ag | Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof |
DE4411025A1 (de) * | 1994-03-30 | 1995-10-05 | Hoechst Ag | Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
EP0933422A4 (de) | 1996-06-13 | 2005-02-02 | Fujisawa Pharmaceutical Co | Zyclische lipopeptid acylase |
DK0909184T3 (da) | 1996-07-03 | 2003-12-22 | Upjohn Co | Målrettet lægemiddelindgivelse ved anvendelse af sulfonamidderivater |
AU9649598A (en) | 1997-10-29 | 1999-05-17 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a, 11,12-carbamate derivatives |
CA2330611A1 (en) * | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
CA2394350A1 (en) * | 1999-12-15 | 2001-06-21 | Cubist Pharmaceuticals, Inc. | Lipopeptides as antibacterial agents |
-
2001
- 2001-01-12 US US09/760,328 patent/US6511962B1/en not_active Expired - Fee Related
- 2001-07-17 WO PCT/US2001/022353 patent/WO2002005838A1/en active Application Filing
- 2001-07-17 JP JP2002511770A patent/JP2004528268A/ja not_active Withdrawn
- 2001-07-17 AT AT01957162T patent/ATE376557T1/de not_active IP Right Cessation
- 2001-07-17 DE DE60138629T patent/DE60138629D1/de not_active Expired - Lifetime
- 2001-07-17 AT AT01953501T patent/ATE430575T1/de not_active IP Right Cessation
- 2001-07-17 AU AU2001275943A patent/AU2001275943B2/en not_active Ceased
- 2001-07-17 EP EP01957162A patent/EP1311281B1/de not_active Expired - Lifetime
- 2001-07-17 CA CA002450747A patent/CA2450747A1/en not_active Abandoned
- 2001-07-17 CA CA002450372A patent/CA2450372A1/en not_active Abandoned
- 2001-07-17 EP EP01953501A patent/EP1309336B1/de not_active Expired - Lifetime
- 2001-07-17 DK DK01953501T patent/DK1309336T3/da active
- 2001-07-17 AU AU7594301A patent/AU7594301A/xx active Pending
- 2001-07-17 JP JP2002511769A patent/JP2004529065A/ja not_active Withdrawn
- 2001-07-17 DE DE60131085T patent/DE60131085T2/de not_active Expired - Lifetime
-
2003
- 2003-08-21 HK HK03105986.2A patent/HK1053613A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1309336A1 (de) | 2003-05-14 |
CA2450372A1 (en) | 2002-01-24 |
DK1309336T3 (da) | 2009-08-24 |
ATE376557T1 (de) | 2007-11-15 |
DE60138629D1 (de) | 2009-06-18 |
EP1311281B1 (de) | 2007-10-24 |
EP1311281A1 (de) | 2003-05-21 |
US6511962B1 (en) | 2003-01-28 |
DE60131085T2 (de) | 2008-08-14 |
EP1311281A4 (de) | 2005-08-24 |
JP2004529065A (ja) | 2004-09-24 |
DE60131085D1 (de) | 2007-12-06 |
JP2004528268A (ja) | 2004-09-16 |
CA2450747A1 (en) | 2002-01-24 |
EP1309336B1 (de) | 2009-05-06 |
AU7594301A (en) | 2002-01-30 |
WO2002005838A1 (en) | 2002-01-24 |
HK1053613A1 (en) | 2003-10-31 |
EP1309336A4 (de) | 2005-01-05 |
AU2001275943B2 (en) | 2006-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002044156A3 (en) | Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors | |
ATE340171T1 (de) | Piperazinderivate zur behandlung bakterieller infektionen | |
BRPI0415288A (pt) | composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto | |
AU2003220970A1 (en) | Diamino-pyrimidines and their use as angiogenesis inhibitors | |
NO20012774D0 (no) | Preparat og metode hvor det gjöres bruk av eteriske planteoljer | |
DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
WO2003099217A3 (en) | Methods of treating bacterial infections and diseases associated therewith | |
ATE430575T1 (de) | Laspartomycin-derivate, sowie ihre herstellung und verwendung | |
WO2001090389A3 (en) | Production of silk-like proteins in plants | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
NO20044549L (no) | Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer | |
SE0003476D0 (sv) | Compounds | |
TW200602295A (en) | Organic compounds | |
ATE339202T1 (de) | Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs | |
NO20044550L (no) | Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer | |
WO2002041831A3 (en) | Inositol derivatives for increasing chloride secretion and inhibiting inflammation | |
ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
ATE328898T1 (de) | Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung | |
WO2003024996A3 (de) | Antibakterielle makrozyklen | |
UA66932C2 (en) | Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine | |
AU2003258176A1 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
PT1276722E (pt) | Inibidores de naftamidina-uroquinase | |
NO20042711L (no) | Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum | |
AU2003258177A1 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |